Impact of Primary Tumour Location and Early Tumour Shrinkage on Outcomes in Patients with RAS Wild-Type Metastatic Colorectal Cancer Following First-Line FOLFIRI Plus Panitumumab

OBJECTIVE: Data from a trial of first-line panitumumab plus FOLFIRI (folinic acid, infusional 5-fluorouracil and irinotecan) in metastatic colorectal cancer were retrospectively analysed to investigate the effects of primary tumour location and early tumour shrinkage on outcomes. METHODS: Patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Köhne, Claus-Henning, Karthaus, Meinolf, Mineur, Laurent, Thaler, Josef, Van den Eynde, Marc, Gallego, Javier, Koukakis, Reija, Berkhout, Marloes, Hofheinz, Ralf-Dieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738356/
https://www.ncbi.nlm.nih.gov/pubmed/31300973
http://dx.doi.org/10.1007/s40268-019-0278-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738356/
https://www.ncbi.nlm.nih.gov/pubmed/31300973
http://dx.doi.org/10.1007/s40268-019-0278-8

Ejemplares similares